Sectors
FENC
Fennec Pharmaceuticals Inc.
12.31
2 x 8.84
2 x 15.06
bid
ask
+
0.04
0.29%
03:07 PM
timesize
| Ytd | 59.81% | |
| 1y | 38.73% |
12.07
day range
12.69
5.65
52 week range
13.25
| Open | 12.36 | Prev Close | 12.27 | Low | 12.07 | High | 12.69 | Mkt Cap | 431.33M |
| Vol | 282.78K | Avg Vol | 225.75K | EPS | -0.12 | P/E | N/A | Forward P/E | 16.78 |
| Beta | 1.09 | Short Ratio | 13.06 | Inst. Own | 54.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 10.78 | 200-d Avg | 8.53 | 1yr Est | 13.60 |
| Income Statement | |||
| Total Revenue | 17.87M | ||
| Revenues (USD) | 17.87M | ||
| Cost of Revenue | 721.00K | ||
| Gross Profit | 17.15M | ||
| Operating Expenses | 15.42M | ||
| Research and Development Expense | 118.00K | ||
| Selling, General and Administrative Expense | 15.30M | ||
| Operating Income | 1.74M | ||
| Interest Expense | 3.00K | ||
| Income Tax Expense | 42.00K | ||
| Net Income | 1.97M | ||
| Net Income Common Stock | 1.97M | ||
| Net Income Common Stock (USD) | 1.97M | ||
| Consolidated Income | 1.97M | ||
| Earnings per Basic Share | 0.06 | ||
| Earnings per Basic Share (USD) | 0.06 | ||
| Earnings per Diluted Share | 0.05 | ||
| Earning Before Interest & Taxes (EBIT) | 2.02M | ||
| Earning Before Interest & Taxes (USD) | 2.02M | ||
| Weighted Average Shares | 34.55M | ||
| Weighted Average Shares Diluted | 36.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.25M | ||
| Cash and Equivalents (USD) | 41.25M | ||
| Trade and Non-Trade Receivables | 25.85M | ||
| Current Assets | 72.50M | ||
| Total Assets | 75.75M | ||
| Current Liabilities | 12.39M | ||
| Total Liabilities | 33.31M | ||
| Accumulated Retained Earnings (Deficit) | -227.25M | ||
| Accumulated Other Comprehensive Income | 1.24M | ||
| Shareholders Equity | 42.44M | ||
| Shareholders Equity (USD) | 42.44M | ||
| Assets Non-Current | 3.25M | ||
| Deferred Revenue | 24.10M | ||
| Inventory | 2.37M | ||
| Liabilities Non-Current | 20.92M | ||
| Trade and Non-Trade Payables | 5.52M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.00K | ||
| Net Cash Flow from Financing | 1.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.07M | ||
| Net Cash Flow from Operations | 50.00K | ||
| Share Based Compensation | 1.77M | ||